Inloggen

Login
 
Wachtwoord vergeten?

Iovance Biotherapeutics

3 Posts
| Omlaag ↓
  1. forum rang 4 Wil Helmus 6 april 2019 11:27
    Iovance Biotherapeutics, voorheen Lion Therapeutics, werkt aan de genezing van kanker en ontwikkelt transformatieve immuno-oncologische TIL-therapieën die het immuunsysteem van een patiënt beïnvloeden. Iovance voert vijf klinische fase II-onderzoeken uit.

    Het gemiddelde koersdoel is $25.00. De koers is de afgelopen tijd al behoorlijk opgelopen maar er zit beslist meer in het vat. Het aandeel staat op de vijfde positie in het hedge fonds van superbelegger Joseph Edelman.
    Zie ook www.iovance.com.
  2. Iovance Biotherapeutics 6 april 2019 11:40
    Shares of Iovance Biotherapeutics, medicine and lariat prescription drugs took it on the chin within the fourth quarter, however each corporations appear able to reward shareholders for his or her patience.There's no substitute for a room to induce nice ideas, thus Jim Cramer created a stronger one at Real cash and blogs there solely. we tend to then interplanetary legendary hedge fund manager, Doug Kass, together with his exclusive Daily Diary and best finance ideas. if you want good essay service? please visit:(https://essayservices.org/)Staffed with quite four dozen finance professionals, cash managers, journalists and analysts, Real cash professional provides you a flood of opinions, analysis and actionable.

  3. forum rang 4 Wil Helmus 11 april 2019 20:11
    Institutional investors purchased a net $21.1 million shares of IOVA during the quarter ended December 2018 and now own 94.96% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
3 Posts
|Omhoog ↑

Plaats een reactie

Meedoen aan de discussie?

Word nu gratis lid of log in met je emailadres en wachtwoord

Direct naar Forum

Indices

AEX 650,30 0,00%
EUR/USD 1,2095 +0,14%
Germany30^ 13.895,30 +0,34%
Gold spot 1.837,44 +0,00%
LDN100-24h 6.753,44 +0,24%
NY-Nasdaq Composite 12.998,50 -0,87%

Stijgers

AALBER...
0,00%
ABN AM...
0,00%
Accell
0,00%
Accsys
0,00%
Acomo
0,00%

Dalers

AALBER...
0,00%
ABN AM...
0,00%
Accell
0,00%
Accsys
0,00%
Acomo
0,00%
 
Quotedata: Amsterdam realtime by Euronext, other realtime by Cboe Europe Ltd.   US stocks: by NYSE & Cboe BZX Exchange, 15min delayed
#/^ Index indications calculated real time, zie disclaimer, streaming powered by Infront. Crypto data by Crypto Compare